INNOSPEC INC. IOSP
Nasdaq · XNAS · stock · Chemicals & Allied Products
Chart by TradingView
3/9
Piotroski F — financial health
7.54
Altman Z″ — distress risk · safe
—
Dividend payout · n/a
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $1.8B | — | $492.4M | — | $1.3B |
| 2024 | $1.8B | — | $542.9M | — | $1.2B |
| 2023 | $1.9B | — | $591.1M | — | $1.1B |
| 2022 | $2.0B | — | $586.7M | — | $1.0B |
| 2021 | $1.5B | — | $434.9M | — | $1.0B |
| 2020 | $1.2B | — | $342.7M | — | $944.9M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Jones David B. | SVP, GC & CCO | 2026-03-03 | Sell | 1,028 | $75.64 |
| PADFIELD Larry | director | 2026-02-27 | Sell | 594 | $76.56 |
| Poccia Claudia | director | 2026-02-27 | Sell | 119 | $76.56 |
| GRIFFIN HARDY LOUIS III | SVP, HUMAN RESOURCES | 2026-02-27 | Tax withheld | 401 | $78.34 |
| LANDLESS DAVID | director | 2026-02-27 | Sell | 594 | $76.56 |
| Jones David B. | SVP, GC & CCO | 2026-02-27 | Tax withheld | 875 | $78.34 |
| BARNES CORBIN | SVP, Corporate Dev and IR | 2026-02-27 | Tax withheld | 166 | $78.34 |
| Cleminson Ian | EVP & CFO | 2026-02-27 | Sell | 2,380 | $76.56 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 7.54 (safe)
- Working capital / assets 0.352
- Retained earnings / assets 0.6
- EBIT / assets 0.071
- Equity / liabilities 2.668
Source: SEC EDGAR filings · CIK 0001054905 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.